SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Year: 1998
Type: article
Institution: Sanofi (France)
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2150206249
